Wejse_edit.qxp 16/7/08 12:52 pm Page 110
Bacterial Infections
cured lupus vulgaris, Photodermatol Photoimmunol Photomed, 48. Hayes CE, Nashold FE, Spach KM, Pedersen LB, The 71. Martineau AR, Wilkinson RJ, Wilkinson KA, et al. A Single
2005;21(3):118–24. immunological functions of the vitamin D endocrine system, Dose of Vitamin D Enhances Immunity to Mycobacteria, Am J
17. Charpy J, Aspects of vitamin and functional substance therapy Cell Mol Biol (Noisy-Le-Grand), 2003;49(2):277–300. Respir Crit Care Med, 2007;176(2):208–13.
in dermatology, Bull Med, 1950;64(24):555–9. 49. Manolagas SC, Hustmyer FG, Yu XP, 1,25-Dihydroxyvitamin D3 72. Davies PD, Brown RC, Woodhead JS, Serum concentrations of
18. Dowling GB, Prosser Thomas EW, Treatment of lupus vulgaris and the immune system, Proc Soc Exp Biol Med, 1989;191(3): vitamin D metabolites in untreated tuberculosis, Thorax,
with calciferol, Lancet, 1946;1:919–22. 238–45. 1985;40(3):187–90.
19. Riehl, Two years experience with vitamin D2 in the treatment 50. Deluca HF, Cantorna MT, Vitamin D: its role and uses in 73. Davies PD, Church HA, Brown RC, Woodhead JS, Raised serum
of tuberculosis of the skin, Arch Klin Exp Dermatol, 1950;191: immunology, FASEB J, 2001;15(14):2579–85. calcium in tuberculosis patients in Africa, Eur J Respir Dis,
615–18. 51. Mahon BD, Wittke A, Weaver V, Cantorna MT, The targets of 1987;71(5):341–4.
20. Ruiter M, Groen HD, The effect of nonirradiated ergosterol in vitamin D depend on the differentiation and activation status 74. Grange JM, Davies PD, Brown RC, et al., A study of vitamin D
calciferol-treated tuberculosis cutis, Dermatologica, of CD4 positive T cells, J Cell Biochem, 2003;89(5):922–32. levels in Indonesian patients with untreated pulmonary
1949;99(6):345–52. 52. Gauzzi MC, Purificato C, Donato K, et al. Suppressive effect of tuberculosis, Tubercle, 1985;66(3):187–91.
21. Gutierrez PD, Fernandez MC, Vitamin D2 in cutaneous 1alpha,25-dihydroxyvitamin D3 on type I IFN-mediated 75. Olmos JM, Martinez J, Riancho JA, et al., Phosphocalcium
tuberculosis; (progress report), Acta Med Philipp, 1950;7(1): monocyte differentiation into dendritic cells: impairment of metabolism disorders in patients with active pulmonary
55–9. functional activities and chemotaxis, J Immunol, 2005;174(1): tuberculosis, Med Clin (Barc), 1991;96(3):92–4.
22. Thaler E, Treatment of tuberculosis of the skin with massive 270–76. 76. Chan TY, Poon P, Pang J, et al., A study of calcium and
doses of vitamin D2, Med Monatsschr, 1950;4(6):452–4. 53. Raja A Immunology of tuberculosis, Indian J Med Res, vitamin D metabolism in Chinese patients with pulmonary
23. Macrae DE The use of calciferol in tuberculous conditions, 2004;120(4):213–32. tuberculosis, J Trop Med Hyg, 1994;97(1):26–30.
Lancet, 1947;249(6439):135–7. 54. Cantorna MT, Zhu Y, Froicu M, Wittke A, Vitamin D status, 77. Sasidharan PK, Rajeev E, Vijayakumari V, Tuberculosis and
24. Lomholt S, Calciferol therapy of lupus vulgaris, Acta Derm 1,25-dihydroxyvitamin D3, and the immune system, Am J Clin vitamin D deficiency, J Assoc Physicians India, 2002;50:
Venereol, 1950;30(4):329–33. Nutr, 2004;80(Suppl. 6):1717S–20S. 554–8.
25. Pogorzelski J, Miedzinski F, Six years of calciferol therapy in 55. Daniel C, Schlauch T, Zugel U, et al., 22-ene-25-oxa-vitamin D: 78. Wilkinson RJ, Llewelyn M, Toossi Z, et al., Influence of vitamin
tuberculosis of the skin, Dermatologica, 1954;109(6):355–69. a new vitamin D analogue with profound immunosuppressive D deficiency and vitamin D receptor polymorphisms on
26. Ellman P, Anderson K, Calciferol in Tuberculosis Peritonitis capacities, Eur J Clin Invest, 2005;35(5):343–9. tuberculosis among Gujarati Asians in west London: a case-
with Disseminated Tuberculosis, BMJ, 1948;1:394. 56. Crowle AJ, Ross EJ, May MH, Inhibition by 1,25(OH)2-vitamin control study, Lancet, 2000;355(9204):618–21.
27. Wallis HR, Tuberculous mesenteric adenitis in children, D3 of the multiplication of virulent tubercle bacilli in cultured 79. Ustianowski A, Shaffer R, Collin S, et al., Prevalence and
Br Med J, 1955;1(4906):128–33. human macrophages, Infect Immun, 1987;55(12):2945–50. associations of vitamin D deficiency in foreign-born persons
28. Gerecke W, Vitamin D2 alone and in combination with TB 57. Crowle AJ, Salfinger M, May MH, 1,25(OH)2-vitamin D3 with tuberculosis in London, J Infect, 2005;50(5):432–7.
1/698 in the treatment of pulmonary tuberculosis, Z Tuberk, synergizes with pyrazinamide to kill tubercle bacilli in 80. Wejse C, Olesen R, Rabna P, et al., Serum 25-hydroxy-vitamin
1950;95(3–4):182–7. cultured human macrophages, Am Rev Respir Dis, 1989;39(2): D in a West African population of tuberculosis patients and
29. Brincourt J, Liquefying effect on suppurations of an oral dose 549–52. un-matched healthy controls, Am J Clin Nutr, 2007;86(5):
of calciferol, Presse Med, 1969;77(13):467–70. 58. Crowle AJ, Ross EJ, Comparative abilities of various 1376–83.
30. Ghosh PK, Vitamin D2 in tuberculosis, J Indian Med Assoc, metabolites of vitamin D to protect cultured human 81. Stead WW, Senner JW, Reddick WT, Lofgren JP, Racial
1957;29(3):90–93. macrophages against tubercle bacilli, J Leukoc Biol, differences in susceptibility to infection by Mycobacterium
31. Trautwein H, Stein E, Vitamin D2 and pulmonary tuberculosis; 1990;47(6):545–50. tuberculosis, N Engl J Med, 1990;322(7):422–7.
effects and therapeutic results, Beitr Klin Tuberk Spezif 59. Crowle AJ, May MH, Inhibition of tubercle bacilli in cultured 82. Harris SS, Vitamin D and African Americans, J Nutr,
Tuberkuloseforsch, 1952;107(4):295–313. human macrophages by chloroquine used alone and in 2006;136(4):1126–9.
32. Gertler W, The question of late injuries in long lasting vitamin combination with streptomycin, isoniazid, pyrazinamide, and 83. Bornman L, Campbell SJ, Fielding K, et al., Vitamin D receptor
D treatment of cutaneous tuberculosis, Z Tuberk, two metabolites of vitamin D3, Antimicrob Agents Chemother, polymorphisms and susceptibility to tuberculosis in West
1953;103(1–3):26–50. 1990;34(11):2217–22. Africa: a case-control and family study, J Infect Dis,
33. Kalkoff KW, Chemotherapy and vitamin D therapy of skin 60. Denis M, Killing of Mycobacterium tuberculosis within human 2004;190(9):1631–41.
tuberculosis, Ergeb Gesamten Tuberkuloseforsch, 1956;13: monocytes: activation by cytokines and calcitriol, Clin Exp 84. Olesen R, Wejse C, Velez DR, et al., DC-SIGN (CD209),
331–70. Immunol, 1991;84(2):200–6. pentraxin 3 and vitamin D receptor gene variants associate
34. Winterberg H, Vigantol therapy in early tuberculous infections 61. Chandra G, Selvaraj P, Jawahar MS, et al., Effect of Vitamin with pulmonary tuberculosis risk in West Africans, Genes
of the lungs, and in exsudative pulmonary tuberculosis, D(3) on Phagocytic Potential of Macrophages with Live Immun, 2007;8(6):456–67.
Z Tuberk, 1950;95(3–4):146–50. Mycobacterium tuberculosis and Lymphoproliferative Response 85. Roth DE, Soto G, Arenas F, et al., Association between vitamin
35. Marcussen PV, Treatment of lupus vulgaris with calciferol in Pulmonary Tuberculosis, J Clin Immunol, 2004;24(3): D receptor gene polymorphisms and response to treatment of
alone; results after five years of observation, Dan Med Bull, 249–57. pulmonary tuberculosis, J Infect Dis, 2004;190(5):920–27.
1955;2(5):129–36. 62. Rockett KA, Brookes R, Udalova I, et al., 1,25- 86. Lewis SJ, Baker I, Davey SG, Meta-analysis of vitamin D
36. Seeber F, The use of vitamin D2 in the treatment of pulmonary Dihydroxyvitamin D3 induces nitric oxide synthase and receptor polymorphisms and pulmonary tuberculosis risk,
tuberculosis, Z Tuberk, 1950;95(3-4):151–5. suppresses growth of Mycobacterium tuberculosis in a human Int J Tuberc Lung Dis, 2005;9(10):1174–7.
37. Holick MF, Resurrection of vitamin D deficiency and rickets, macrophage-like cell line, Infect Immun, 1998;66(11): 87. Soborg C, Andersen AB, Range N, et al., Influence of
J Clin Invest, 2006;116(8):2062–72. 5314–21. candidate susceptibility genes on tuberculosis in a high
38. Vieth R, Vitamin D supplementation, 25-hydroxyvitamin D 63. Liu PT, Stenger S, Li H, et al., Toll-like receptor triggering of a endemic region, Mol Immunol, 2007;44(9):2213–20. Epub
concentrations, and safety, Am J Clin Nutr, 1999;69(5): vitamin D-mediated human antimicrobial response, Science, 2006 Dec 6.
842–56. 2006;311(5768):1770–73. 88. Morcos MM, Gabr AA, Samuel S, et al., Vitamin D
39. Hathcock JN, Shao A, Vieth R, Heaney R, Risk assessment for 64. Waters WR, Nonnecke BJ, Rahner TE, et al., Modulation of administration to tuberculous children and its value, Boll Chim
vitamin D, Am J Clin Nutr, 2007;85(1):6–18. Mycobacterium bovis-specific responses of bovine peripheral Farm, 1998;137(5):157–64.
40. Fruhwald R, Changes in the blood analysis in vitamin D2 blood mononuclear cells by 1,25-dihydroxyvitamin D(3), Clin 89. awn SD, Macallan DC, Hypercalcemia: a manifestation of
treatment of cutaneous tuberculosis, Dtsch Gesundheitsw, Diagn Lab Immunol, 2001;8(6):1204–12. immune reconstitution complicating tuberculosis in an HIV-
1953;8(3):67–9. 65. Waters WR, Palmer MV, Nonnecke BJ, et al., Mycobacterium infected person, Clin Infect Dis, 2004;38(1):154–5.
41. Sonne LM, Calciferol in dermatology, Ugeskr Laeger, bovis infection of vitamin D-deficient NOS2-/- mice, Microb 90. Bradley GW, Sterling GM, Hypercalcaemia and hypokalaemia
1952;114(4):109–13. Pathog, 2004;36(1):11–17. in tuberculosis, Thorax 1978;33(4):464–7.
42. Dowling GB, The present status of vitamin D2 in the treatment 66. Cadranel JL, Garabedian M, Milleron B, et al., Vitamin D 91. Lind L, Ljunghall S, Hypercalcemia in pulmonary tuberculosis,
of lupus vulgaris, Dermatologica, 1957;115(4):491–5. metabolism by alveolar immune cells in tuberculosis: Ups J Med Sci, 1990;95(2):157–60.
43. Fielding J, Maloney JJ, Calciferol, streptomycin, and para- correlation with calcium metabolism and clinical 92. Roussos A, Lagogianni I, Gonis A,et al., Hypercalcaemia in
aminosalicylic acid in pulmonary tuberculosis, Lancet, manifestations, Eur Respir J, 1994;7(6):1103–10. Greek patients with tuberculosis before the initiation of anti-
1951;2(14):614–17. 67. Zehnder D, Bland R, Williams MC, et al., Extrarenal expression tuberculosis treatment, Respir Med, 2001;95(3):187–90.
44. Jongmans LJ, Hopmans PJ, Kars HJ, Michgelsen H, Danger of of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase, J Clin 93. Chan TY, Symptomatic hypercalcaemia is rare in tuberculous
reactivating tuberculous processes in the lungs with the Endocrinol Metab, 2001;86(2):888–94. patients in Hong Kong, Ann Trop Med Parasitol, 1996;90(6):
administration of massive doses of vitamin D2, Ned Tijdschr 68. Sharma OP, Hypercalcemia in granulomatous disorders: a 663–4.
Geneeskd, 1950;94(34):2470–73. clinical review, Curr Opin Pulm Med, 2000;6(5):442–7. 94. Tan TT, Lee BC, Khalid BA, Low incidence of hypercalcaemia in
45. Grassi A, Modern therapy of cutaneous tuberculosis, Minerva 69. Rook GA, Taverne J, Leveton C, Steele J, The role of gamma- tuberculosis in Malaysia, J Trop Med Hyg, 1993;96(6):349–51.
Med, 1957;48(51):2269–73. interferon, vitamin D3 metabolites and tumour necrosis factor 95. Kelestimur F, Guven M, Ozesmi M, Pasaoglu H, Does
46. Provvedini DM, Tsoukas CD, Deftos LJ, Manolagas SC, 1,25- in the pathogenesis of tuberculosis, Immunology, 1987;62(2): tuberculosis really cause hypercalcemia?, J Endocrinol Invest,
dihydroxyvitamin D3 receptors in human leukocytes, Science, 229–34. 1996;19(10):678–81.
1983;221(4616):1181–3. 70. Stabel JR, Goff JP, Influence of vitamin D3 infusion and dietary 96. Fuss M, Karmali R, Pepersack T, et al., Are tuberculous
47. Veldman CM, Cantorna MT, DeLuca HF, Expression of 1,25- calcium on secretion of interleukin 1, interleukin 6, and tumor patients at a great risk from hypercalcemia?, Q J Med,
dihydroxyvitamin D(3) receptor in the immune system, Arch necrosis factor in mice infected with Mycobacterium 1988;69(259):869–78.
Biochem Biophys, 2000;374(2):334–8. paratuberculosis, Am J Vet Res, 1996;57(6):825–9.
110 EUROPEAN INFECTIOUS DISEASE
Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112  |  Page 113  |  Page 114  |  Page 115  |  Page 116  |  Page 117  |  Page 118  |  Page 119  |  Page 120  |  Page 121  |  Page 122  |  Page 123  |  Page 124  |  Page 125  |  Page 126  |  Page 127  |  Page 128  |  Page 129  |  Page 130  |  Page 131  |  Page 132